NO991529L - FremgangsmÕte for Õ rense GBS-toksin/CM101 - Google Patents

FremgangsmÕte for Õ rense GBS-toksin/CM101

Info

Publication number
NO991529L
NO991529L NO991529A NO991529A NO991529L NO 991529 L NO991529 L NO 991529L NO 991529 A NO991529 A NO 991529A NO 991529 A NO991529 A NO 991529A NO 991529 L NO991529 L NO 991529L
Authority
NO
Norway
Prior art keywords
procedure
purifying
product
gbs toxin
bacterial
Prior art date
Application number
NO991529A
Other languages
English (en)
Norwegian (no)
Other versions
NO991529D0 (no
Inventor
Carl G Hellerqvist
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of NO991529D0 publication Critical patent/NO991529D0/no
Publication of NO991529L publication Critical patent/NO991529L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO991529A 1996-09-30 1999-03-29 FremgangsmÕte for Õ rense GBS-toksin/CM101 NO991529L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/744,770 US5811403A (en) 1996-09-30 1996-09-30 Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
PCT/US1997/017535 WO1998014603A1 (en) 1996-09-30 1997-09-30 Method for purifying gbs toxin/cm101

Publications (2)

Publication Number Publication Date
NO991529D0 NO991529D0 (no) 1999-03-29
NO991529L true NO991529L (no) 1999-05-19

Family

ID=24993931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991529A NO991529L (no) 1996-09-30 1999-03-29 FremgangsmÕte for Õ rense GBS-toksin/CM101

Country Status (18)

Country Link
US (4) US5811403A (de)
EP (1) EP0932696B1 (de)
JP (2) JP2001504144A (de)
KR (1) KR20000048757A (de)
CN (1) CN1192115C (de)
AR (1) AR011238A1 (de)
AT (1) ATE284449T1 (de)
AU (1) AU4802697A (de)
BR (1) BR9712167A (de)
CA (1) CA2265696C (de)
DE (1) DE69731891T2 (de)
DK (1) DK0932696T3 (de)
ES (1) ES2235228T3 (de)
HR (1) HRP970525A2 (de)
IL (1) IL129162A0 (de)
NO (1) NO991529L (de)
WO (1) WO1998014603A1 (de)
ZA (1) ZA978754B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5981508A (en) * 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6803448B1 (en) 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US8609614B2 (en) * 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
WO2000005375A1 (en) * 1998-07-22 2000-02-03 Vanderbilt University Gbs toxin receptor
CN100540675C (zh) * 2006-12-06 2009-09-16 云南沃森生物技术有限公司 一种使用Sepharose 4FF凝胶对细菌多糖进行纯化的方法
ES2375314T3 (es) 2007-02-28 2012-02-28 Lipoxen Technologies Limited Reducción de endotoxina en ácidos polisiálicos.
CN102757516B (zh) * 2012-08-03 2014-06-18 常州千红生化制药股份有限公司 依诺肝素钠的脱色方法
WO2017090047A1 (en) 2015-11-27 2017-06-01 Technology Innovation Momentum Fund (Israel) Limited Partnership Glucosamine and derivatives thereof in imaging
CN114702558B (zh) * 2022-04-06 2023-09-15 四川奥邦投资有限公司 一种新型葡甘杂聚糖肽及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS557014A (en) * 1978-06-29 1980-01-18 Chugai Pharmaceut Co Ltd Antitumor agent and its preparation
JPS5740503A (en) * 1980-08-22 1982-03-06 Seikagaku Kogyo Co Ltd Separation of saccharides
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
US4882317A (en) * 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5050062A (en) * 1989-02-06 1991-09-17 Hass David N Temperature controlled fluid system
US5010062A (en) * 1989-09-25 1991-04-23 Vanderbilt University Therapeutic agent and method of inhibiting vascularization of tumors
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity

Also Published As

Publication number Publication date
ES2235228T3 (es) 2005-07-01
US6407069B1 (en) 2002-06-18
IL129162A0 (en) 2000-02-17
CN1235642A (zh) 1999-11-17
BR9712167A (pt) 2000-01-18
JP2009173945A (ja) 2009-08-06
WO1998014603A1 (en) 1998-04-09
AR011238A1 (es) 2000-08-16
CA2265696A1 (en) 1998-04-09
ATE284449T1 (de) 2004-12-15
CA2265696C (en) 2009-12-08
JP2001504144A (ja) 2001-03-27
ZA978754B (en) 1998-03-23
CN1192115C (zh) 2005-03-09
DE69731891T2 (de) 2005-12-01
DK0932696T3 (da) 2005-03-14
US5811403A (en) 1998-09-22
US6136789A (en) 2000-10-24
HRP970525A2 (en) 1998-08-31
AU4802697A (en) 1998-04-24
DE69731891D1 (de) 2005-01-13
HK1025602A1 (en) 2000-11-17
US5939396A (en) 1999-08-17
NO991529D0 (no) 1999-03-29
EP0932696B1 (de) 2004-12-08
KR20000048757A (ko) 2000-07-25
EP0932696A1 (de) 1999-08-04

Similar Documents

Publication Publication Date Title
Snyderman et al. Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth component of complement by macrophage proteinase
ES8504458A1 (es) Procedimiento para producir la subunidad a la toxina del colera.
MY120964A (en) Television apparatus for simultaneous decoding of auxiliary data included in multiple television signals
CA2181324A1 (en) Multiple data stream searching method and apparatus
AU7684198A (en) Method and apparatus for time-shifting video and text in a text-enhanced television program
DK1724354T3 (da) Cirkulær DNA-molekyle med en afhængig replikationsoprindelse, fremgangsmåde til fremstilling heraf og anvendelse heraf i genterapi
NO991784L (no) Purin-L-nukleosider, analoger og anvendelser derav
CA2179223A1 (en) Method and apparatus for controlling the operation of a signal decoder in a broadcasting system
AU1266095A (en) Sugar beet juice purification process
IL110666A0 (en) Gel cassette for enhanced electrophoretic separation and preparation thereof
SE8605286L (sv) Forfarande for avkodning av data overforda utmed en datakanal och en apparat for utforande av forfarandet
BR9712167A (pt) Processo de purificação de uma toxina de polissacarìdeo das bactérias gbs, toxina das bactérias gbc, composição farmacêutica, e, processos de tratamento de um paciente tendo uma condição médicae com um tumor.
AU1722997A (en) Natamycin recovery
ES8506806A1 (es) Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa
RU94002793A (ru) Способ выделения дигидрокверцетина
HK63795A (en) Antibiotic polypeptide, process for its preparation and its use
GB2102291A (en) Method for purifying polyosides of streptococcus pneumoniae and vaccine based on polyosides thus purified
Qihong et al. Isolation, identification and stability analysis of antioxidant peptides from Moringa oleifera seeds
GB1318570A (en) Protein separation
FR2429765A1 (fr) Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur
EP0773030B8 (de) Reinigungsverfahren für von bordetella bronchiseptica produziertes dermonekrotisches toxin
Ohkuchi et al. Purification and Identification of a Stimulator of PGI2 Production from Human Placenta
WO1991012691A3 (en) Hd-mac television decoder
OKITA Identification of tyramine and octopamine in human serum by mass fragmentography
AU6824200A (en) Column chromatography separation method